GLP-1 receptor agonists typically produce weight reduction and HbA1c decreases that vary by medication and dose
Abstract Peptides have gained so much attention in the last decade that they are now part of the main strategies, with small molecules and biologics, for developing new medicines
So what IS the biohack
Zheng J, Mitchell AE, Jones AD, Hammock BD
from week 0 to week 68 for the second objective) in body weight (% and kg), BMI, systolic and diastolic blood pressure (SBP and DBP), CRP, HbA1c and lipids, including triglycerides, total cholesterol, highdensity lipoprotein (HDL) cholesterol, lowdensity lipoprotein (LDL) cholesterol, verylowdensity lipoprotein (VLDL) cholesterol and free fatty acids (the latter for the second exploratory objective only, because of different fasting conditions in the main and extension phases)
For PatchMD, this growth represents both an opportunity and a responsibility